Literature DB >> 34608582

Effect of Amelotin on Bone Growth in the Murine Calvarial Defect Model.

Daiki Tanaka1, Yuichi Ikeda2, Eri Ikeda1,3, Mako Yokose1, Bernhard Ganss4, Takanori Iwata1.   

Abstract

Amelotin (AMTN) is a protein that is expressed during the maturation of dental enamel and has important role in enamel hydroxyapatite mineralization. However, it is not well understood whether AMTN has a strong mineral-promoting ability in bone. In this study, the effect of AMTN on bone healing was investigated using mice calvarial defect model in vivo, and the expression of bone marker genes and cell proliferation were investigated to clarify the role of AMTN in bone mineralization using mouse osteogenic cells (MC3T3-E1) in vitro. Collagen membranes, with or without recombinant human (rh) AMTN, were applied to calvarial defects created on the parietal bones of C57BL/6N mice. Microcomputed tomography and histological observation revealed that the defect largely filled with mineralized tissue by the rhAMTN-containing membrane in eight weeks. Moreover, CD31 positive cells were observed in the newly formed mineralized tissue and around the rhAMTN-containing membrane. In the presence of rhAMTN, the expression of the Spp1 gene in MC3T3-E1 cells significantly increased within ten days in an osteoinductive medium. Moreover, rhAMTN significantly enhanced MC3T3-E1 cell proliferation. These findings indicate that AMTN positively influences bone repair by promoting hydroxyapatite mineralization.
© 2021. Biomedical Engineering Society.

Entities:  

Keywords:  Amelotin; Bioengineering; Bone healing; Matrix mineralization; Non-collagenous proteins

Mesh:

Substances:

Year:  2021        PMID: 34608582     DOI: 10.1007/s10439-021-02867-z

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  1 in total

1.  Amelotin Promotes Mineralization and Adhesion in Collagen-Based Systems.

Authors:  Yuichi Ikeda; James Holcroft; Eri Ikeda; Bernhard Ganss
Journal:  Cell Mol Bioeng       Date:  2022-03-27       Impact factor: 3.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.